Norfalk develops bio-based surfactants via biocatalysis for products from shampoos to detergents. CEO Kasper Falkenberg shares the company’s vision, motivation, and the value of its unique platform.
June 23, 2026 | Explore how AI-driven materials informatics is reshaping polymer development, as industry leaders reveal practical strategies for scaling digital platforms and accelerating innovation.
In this CHEManager Leaders & Motivators interview, Frank Romanski, Lonza Capsugel, reflects on how strategy becomes execution and what resilience demands from teams,
REEcover recovers rare earths from e‑waste using a patented, efficient, low‑impact process, offering a sustainable alternative to mining and strengthening circular supply chains.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International
April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.
Expert Insights
Comprehensive Insights into Antibody–Drug Conjugates
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.
Since 2021, the Swiss Biotech Day has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships.
The Pharma Partnering EU Summit 2026 will take place in Basel, Switzerland, on May 20–21, 2026, bringing together global leaders in business development and licensing from pharmaceutical and biotech organizations.
This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
